- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03688672
Apioc Contact Lens Feasibility
January 17, 2022 updated by: Lentechs, LLC
Evaluation of the Feasibility of Fitting of Apioc Contact Lenses in Adults
This clinical trial will document the feasibility of the Apioc lens design by assessing which lens shape parameters yield successful on-eye-fit and movement of the Apioc contact lens design and evaluate the subjectively-reported comfort of the Apioc contact lens design.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This is a one-site, non-dispensing clinical trial using the Apioc contact lens design.
This soft contact lens study will determine the feasibility of this design by determining which parameters of the shape of the Apioc Contact Lens design will yield a successful fit across subjects.
We will also determine the percentage of subjects who can be successfully fitted with the Apioc Contact Lens Design.
Because the feasibility of the lens design may be dependent upon age, a total of 50 subjects (10 subjects each across 5 decades of life) will complete the study.
The data will be collected in a single visit for most subjects.
A few subjects may be asked to return for a second visit if additional contact lens parameters need to be ordered to achieve a successful fit.
The key assessments for this study will be demonstration of feasibility of fit, documentation of movement in all gazes, including translation, and subjective reports of comfort.
Subjects will only wear contact lenses while in the office.
Study Type
Interventional
Enrollment (Actual)
50
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ohio
-
Columbus, Ohio, United States, 43230
- The Ohio State University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 60 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Thirty subjects will be at least 40 years of age and no more than 60 years of age. Ten subjects will be at least 18 years of age and no more than 29 years of age. Ten subjects will be at least 30 years of age and no more than 39 years of age.
- The subject must have ≤ 1.50 D of corneal astigmatism.
- The subject should have clear, healthy corneas.
- The subject should have a normal, healthy conjunctiva in both eyes.
- The subject should be free of active ocular disease. Refractive error and presbyopia are permitted.
- The subject must provide written informed consent.
- The subject must appear willing and able to adhere to the instructions set forth in this protocol.
Exclusion Criteria:
- No irregular corneal astigmatism is permitted.
- No pterygia or corneal scarring that would interfere with contact lens wear.
- No pinguecula or other conjunctival thickness abnormalities are permitted that would interfere with contact lens wear.
- The subject should not be using any ocular pharmaceutical treatments, including artificial tears in the two weeks prior to the examination.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Device Feasibility
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Apioc Lens
All subjects will wear the same, Apioc Contact Lens design.
|
Novel soft contact lens design.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Vertical Movement of Contact Lens in Downgaze
Time Frame: After 15 minutes of on-eye settling
|
Vertical movement of the contact lens relative to the eye in downgaze in millimeters.
|
After 15 minutes of on-eye settling
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Movement of contact lens with blink
Time Frame: After 15 minutes of on-eye settling
|
Movement of contact lens in straight-ahead gaze with a blink in millimeters.
|
After 15 minutes of on-eye settling
|
Visual Acuity
Time Frame: After 15 minutes of on-eye settling
|
logMAR visual acuity at 40 cm through the contact lens with distance correction in trial frame over the Apioc contact lens.
|
After 15 minutes of on-eye settling
|
Comfort questionnaire
Time Frame: After 15 minutes of on-eye settling
|
Subjects will be asked to assess the comfort of each lens by marking an "X" on a line between 0 and 100.
|
After 15 minutes of on-eye settling
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Heidi Wagner, OD, MS, Ohio State University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 1, 2018
Primary Completion (Actual)
October 31, 2020
Study Completion (Actual)
October 31, 2020
Study Registration Dates
First Submitted
September 25, 2018
First Submitted That Met QC Criteria
September 26, 2018
First Posted (Actual)
September 28, 2018
Study Record Updates
Last Update Posted (Actual)
January 19, 2022
Last Update Submitted That Met QC Criteria
January 17, 2022
Last Verified
January 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- LEN001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Presbyopia
-
Johnson & Johnson Vision Care, Inc.CompletedPresbyopia CorrectionUnited Kingdom
-
Bausch & Lomb IncorporatedCompletedMyopia and Hyperopia and PresbyopiaUnited States
-
Technolas Perfect Vision GmbHUnknownHyperopic PresbyopiaIreland
-
Lee, Steven, M.D.CompletedMyopia, | Hyperopia, | Astigmatism, | Presbyopia, | Eye Strain,
-
Allotex, Inc.RecruitingPresbyopiaCzechia, Ireland, Turkey, United Kingdom
-
Coopervision, Inc.Centre for Ocular Research & Education, CanadaRecruitingPresbyopiaUnited States, Canada
-
Optall VisionRecruiting
-
Ji Xing Pharmaceuticals (Shanghai) Co., Ltd.LENZ Therapeutics, IncCompleted
-
Allotex, Inc.TerminatedPresbyopiaBelgium, Ireland, United Kingdom
-
Coopervision, Inc.CORECompletedPresbyopiaUnited States, Canada
Clinical Trials on Apioc Contact Lens Design
-
Lentechs, LLCCompletedContact Lens-Induced Corneal Disorder of Both Eyes (Diagnosis)United States
-
Bausch & Lomb IncorporatedCompleted
-
Lentechs, LLCCompleted
-
Moorfields Eye Hospital NHS Foundation TrustCompleted
-
CIBA VISIONCompleted
-
Bausch & Lomb IncorporatedCompleted
-
Coopervision, Inc.Completed
-
Johnson & Johnson Vision Care, Inc.Visioncare Research Ltd.Completed
-
CIBA VISIONUniversity of WaterlooCompleted